R. White

Developing aptamers into therapeutics.

B. Sullenger, C. Rusconi, B A Sullenger, 2000, The Journal of clinical investigation.

Molecules involved in mammalian sperm-egg interaction.

R. Carballada, C. Dowds, P. Saling, 1998, International review of cytology.

Exome sequencing of 628,388 individuals identifies common and rare variant associations with clonal hematopoiesis phenotypes

J. Marchini, G. Atwal, Y. Houvras, 2022, medRxiv.

Aptamers as Therapeutics.

B. Sullenger, R. Becker, S. Nimjee, 2017, Annual review of pharmacology and toxicology.

Generation of species cross-reactive aptamers using "toggle" SELEX.

B. Sullenger, A. Wolberg, C. Rusconi, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Antidote-mediated control of an anticoagulant aptamer in vivo

George Quick, B. Sullenger, S. Nimjee, 2004, Nature Biotechnology.

RNA aptamer to thrombin binds anion‐binding exosite‐2 and alters protease inhibition by heparin‐binding serpins

B. Sullenger, C. Rusconi, F. Church, 2004, FEBS letters.

A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function

B. Sullenger, Rebekah R White, K. Viles, 2008, Angiogenesis.